Injection of blood products

Hepatitis C - Injection of blood products Factor

Last reviewed for CCPS 30 April 1997.

Investigative Documents

Claimant Report - Transfusion of Blood or Blood Products [CR9012]

[1] Medical Report - Blood Transfusion and Injection of Blood Products - Hepatitis [MR9051]

Preliminary questions [10231]

[2]10249

there is some evidence that a blood products injection may be a factor in the development of the condition under consideration.

7025 [2] the veteran has had a blood product injection at some time.

10250 [3] the veteran had a blood products injection more than 2 weeks before the clinical onset of hepatitis C.

[4]10252

the blood products injection more than 2 weeks before the clinical onset of hepatitis C was screened for hepatitis C.

10253 — the veteran has established the causal connection between the blood product injection and VEA service for the clinical onset of hepatitis C.

10254 — the veteran has established the causal connection between the blood product injection and operational service for the clinical onset of hepatitis C.

10255 — the veteran has established the causal connection between the blood product injection and eligible service for the clinical onset of hepatitis C.

Clinical onset and operational service [10254]

[5]11253

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on operational service.

[6]11254

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on operational service, as a causal result of operational service.

[7]11257

the receipt of the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C, on operational service, was due to the veteran's serious default, wilful act or serious breach of discipline.

[8]10251

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable.

7029 — the identified illness or injury for which the blood product injection was given is causally related to operational service. [9] [10]

Clinical onset and eligible service [10255]

[11]11255

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on eligible service.

[12]11256

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given on eligible service, as a causal result of eligible service duties.

[13]11258

the receipt of the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C, on eligible service, was due to the veteran's serious default, wilful act or serious breach of discipline.

[8]10251

the unscreened blood products injection more than 2 weeks before the clinical onset of hepatitis C was given for treatment of an illness or injury which is identifiable. [9]

10256 — the identified illness or injury for which the blood product injection was given is causally related to eligible service. [14] [10]

Source URL (modified on 20/10/2014 - 3:25pm): https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/h-l/hepatitis-c-a011-b171b182/rulebase-hepatitis-c/injection-blood-products

Links
[1] https://clik.dva.gov.au/ccpsclaimant-13
[2] clikpopup://CCPS/Blood products injection
[3] clikpopup://CCPS/Blood products injection more than 2 weeks prior to onset of hepatitis C
[4] clikpopup://CCPS/reject10250No
[5] clikpopup://CCPS/reject10252No
[6] clikpopup://CCPS/reject11253No
[7] clikpopup://CCPS/reject11254No
[8] clikpopup://CCPS/rejectwilful
[9] clikpopup://CCPS/reject10251No
[10] clikpopup://CCPS/reject7029,10256No
[11] clikpopup://CCPS/Unscreened blood products injection prior to onset of hepatitis C on eligible service
[12] clikpopup://CCPS/reject11255No
[13] clikpopup://CCPS/reject11256No
[14] clikpopup://CCPS/reject10256No